Invention Grant
- Patent Title: Methods of isolation and use of CD39 stromal stem cells
-
Application No.: US16630791Application Date: 2018-07-12
-
Publication No.: US11268067B2Publication Date: 2022-03-08
- Inventor: Stephen J. Elliman , Jack Kavanaugh , Larry A. Couture , Lisa O'Flynn
- Applicant: ORBSEN THERAPEUTICS LIMITED
- Applicant Address: IE Galway
- Assignee: ORBSEN THERAPEUTICS LIMITED
- Current Assignee: ORBSEN THERAPEUTICS LIMITED
- Current Assignee Address: IE Galway
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/IB2018/000939 WO 20180712
- International Announcement: WO2019/012334 WO 20190117
- Main IPC: A61K35/35
- IPC: A61K35/35 ; C12N5/0775 ; A61P25/28 ; A61P1/16 ; A61P37/06 ; A61P19/02 ; A61P13/12 ; A61P17/02 ; A61P11/00 ; A61P29/00 ; A61K9/00 ; A61K9/06 ; G01N33/543
Abstract:
Disclosed herein are methods of isolating SDC2+ stromal stem cells by expression of surface marker CD39. Also disclosed herein are stromal stem cells isolated by said methods.
Public/Granted literature
- US20200149012A1 CD39 STROMAL STEM CELLS METHODS OF ISOLATION AND USE Public/Granted day:2020-05-14
Information query
IPC分类:
